intuniv
takeda pharmaceuticals international ag ireland branch - guanfatsiinvesinikkloriid - tähelepanupuudulikkuse häire koos hüperaktiivsusega - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv tuleb kasutada osana ulatuslikust adhd ravi programm, tavaliselt sealhulgas psühholoogilisi, pedagoogilisi ja sotsiaalseid meetmeid,.
lanvis tablett
aspen pharma trading limited - tioguaniin - tablett - 40mg 25tk
myfortic gastroresistentne tablett
novartis baltics sia - mükofenoolhape - gastroresistentne tablett - 360mg 50tk; 360mg 120tk; 360mg 250tk
octaplaslg infusioonilahus
octapharma (ip) - inimvereplasma proteiinid - infusioonilahus - 70mg 1ml 200ml 10tk; 70mg 1ml 200ml 1tk
verquvo
bayer ag - vericiguat - südamepuudulikkus - südame teraapia - treatment of symptomatic chronic heart failure.